Stroke in patients with sickle cell disease

被引：0
|
作者：
Webb, Jennifer [1 ,2 ]
Kwiatkowski, Janet L. [1 ,2 ]
机构：
[1] Childrens Hosp Philadelphia, Div Hematol, Philadelphia, PA 19104 USA
[2] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA
来源：
EXPERT REVIEW OF HEMATOLOGY | 2013年 / 6卷 / 03期
关键词：
cerebrovascular accident; chronic transfusion therapy; review; sickle cell anemia; stroke; TRANSCRANIAL DOPPLER ULTRASONOGRAPHY; CORD BLOOD TRANSPLANTATION; SILENT CEREBRAL INFARCTS; BONE-MARROW-TRANSPLANTATION; MAGNETIC-RESONANCE ANGIOGRAPHY; CENTRAL-NERVOUS-SYSTEM; MIXED HEMATOPOIETIC CHIMERISM; REDUCE IRON OVERLOAD; TRANSFUSION THERAPY; RECURRENT STROKE;
D O I：
10.1586/EHM.13.25
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Stroke is a significant cause of morbidity and mortality in children and adults with sickle cell disease. Great advances in the past couple of decades have enabled identification and treatment of children at risk of stroke, with a resultant dramatic reduction in stroke incidence in children. However, prevention and treatment of silent cerebral infarcts remain a challenge. This article reviews our current understanding of the epidemiology, risk factors and pathophysiology of small and large vessel disease with a focus on pediatric patients. The presentation and acute management of stroke in patients with sickle cell disease are discussed. Current recommendations for primary and secondary stroke prevention, as well as ongoing research studies and potential new therapies are reviewed.
引用
收藏
页码：301 / 316
页数：16
相关论文
共 50 条
  • [31] SICKLE-CELL DISEASE, MRI, AND STROKE
    PAVLAKIS, SG
    BELLO, J
    INCE, C
    MYER, P
    CIRELLA, B
    HILAL, S
    MOHR, JP
    PIOMELLI, S
    DEVIVO, DC
    ANNALS OF NEUROLOGY, 1986, 20 (03) : 432 - 432
  • [32] Homocysteine in sickle cell disease: Relationship to stroke
    Houston, PE
    Rana, S
    Sekhsaria, S
    Perlin, E
    Kim, KS
    Castro, OL
    AMERICAN JOURNAL OF MEDICINE, 1997, 103 (03): : 192 - 196
  • [33] Neurological PRESentations in Sickle Cell Patients Are Not Always Stroke: A Review of Posterior Reversible Encephalopathy Syndrome in Sickle Cell Disease
    Solh, Ziad
    Taccone, Michael S.
    Marin, Samantha
    Athale, Uma
    Breakey, Vicky R.
    PEDIATRIC BLOOD & CANCER, 2016, 63 (06) : 983 - 989
  • [34] Therapy Insight: stroke risk and its management in patients with sickle cell disease
    Fenella J Kirkham
    Nature Clinical Practice Neurology, 2007, 3 : 264 - 278
  • [35] Therapy Insight: stroke risk and its management in patients with sickle cell disease
    Kirkham, Fenella J.
    NATURE CLINICAL PRACTICE NEUROLOGY, 2007, 3 (05): : 264 - 278
  • [36] Impact of Human Leukocyte Antigen on the Risk of Stroke in Patients with Sickle Cell Disease
    Al-Harrasi, Huda
    Al-Khabori, Murtadha
    Al-Kindi, Salam
    Wali, Yasser Ahmed Mohamed Soliman
    Al Huneini, Mohamed
    Al-Riyami, Hamad
    BLOOD, 2019, 134
  • [37] Genetic Modifiers of Stroke in Patients with Sickle Cell Disease-A Scoping Review
    Oni, Morohuntodun O.
    Brito, Miguel
    Rotman, Chloe
    Archer, Natasha M.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (12)
  • [38] Prevalence of anxiety and depression in sickle cell disease patients post-stroke
    Gragg, C. Q.
    Cotoco, J.
    Tran, A.
    Mack, J. M.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2025, 369 : S381 - S382
  • [39] Trends in Hospital Admissions for Stroke Among Patients With Sickle Cell Disease.
    Esenwa, Charles
    Lekoubou, Alain
    Bishu, Kinfe
    Ovbiagele, Bruce
    STROKE, 2019, 50
  • [40] Characteristics and outcomes of stroke hospitalizations in patients with sickle cell disease and moyamoya syndrome
    Rallo, Michael S.
    Akel, Omar
    Kalakoti, Piyush
    Sun, Hai
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2022, 31 (10):
12345